California State Board of Pharmacy Modifies Language of Proposed Regulation Related to Inventory Reconciliation in Response to Public Comment

By Steven Funk At its December 2, 2021 meeting, the California State Board of Pharmacy (the Board) discussed the pending Inventory Reconciliation regulation and clarified that the proposed regulation intends to require licensees to complete a full inventory reconciliation for Continue reading

The Patient Transparency and Protection Act Seeks to Address Medical Board’s Legislative Request

By Tala Hughes SB 920 (Hurtado), as amended on March 29, 2022, would amend sections 2220.5 and 2330 of, and add section 2220.8 to the Business and Professions Code regarding the Medical Board of California’s (MBC) ability to request records Continue reading

Law Requiring That Most Prescriptions Issued by a Licensed Healthcare Practitioner to a California Pharmacy Must be Submitted Electronically Takes Effect

By Steven Funk On January 1, 2022, section 688 of the Business and Professions Code became effective, requiring that all prescriptions issued by a licensed healthcare practitioner to a California pharmacy must be issued electronically unless specified exemptions are met. Continue reading

California State Board of Pharmacy Intends to Enter the Food and Drug Administration’s Memorandum of Understanding Addressing Certain Distributions of Compounded Human Drug Products

By Steven Funk On April 29-30, 2021, the California Board of Pharmacy (Board) held a meeting [Agenda Item XI(b–c)], where the Board expressed its intention to sign the Food and Drug Administration’s (FDA) Memorandum of Understanding Addressing Certain Distributions of Continue reading

California Pharmacy Board Publishes Notice on Pharmacists Initiating and Administering Vaccines

By Sarah Dahm On October 8, 2021, the Board of Pharmacy (Board) published notice of its intent to amend section 1746.4 of Title 16, Division 17 of the California Code of Regulations (CCR) to permanently waive a requirement of pharmacists Continue reading

Board of Pharmacy Updates Ownership, Management, and Control of Pharmacy License Regulations

By Sarah Dahm On July 23, 2021, the California Board of Pharmacy (Board) issued notice of its proposed rulemaking action to amend section 1709, Title 16 of the California Code of Regulations (CCR). This proposed rulemaking action follows SB 1193 Continue reading

Board of Pharmacy Proposes Regulations to Add Self-Assessment Requirements for Third-Party Logistics Providers and Responsible Managers

By Sarah Dahm On September 17, 2021, the California Board of Pharmacy noticed its proposal to amend section 1784, Title 16 of the CCR to provide clarity with respect to whom the section applies, as third-party logistics providers (3PLs) perform Continue reading

Board’s Proposed Regulation Aims to Curtail the Ongoing Misuse and Abuse of Prescription Medication

By Steven Funk On September 17, 2021, the California Board of Pharmacy published notice of its intent to amend section 1715.65, Title 16 of the California Code of Regulations (CCR) to address frequent compliance questions the Board receives on the Continue reading

Board’s Proposed Amendment on Reporting Pharmacy Drug Loss Undergoing Review by OAL

By Steven Funk On June 4, 2021, the California Board of Pharmacy (BOP) published notice of its intent to amend section 1715.6, Title 16 of the CCR to reduce mandatory reporting of loss of controlled substances, which is set forth Continue reading